Healthcare AccessibilityPatient-Centric ApproachesFuture Healthcare Trendsdiabetesobesityweight loss drugs
Who can get access to GLP1 agonists?
A special family of medications known as glucagon-like peptide-1 receptor agonists (GLP-1) has been licensed for the treatment of both diabetes and obesity. In this video, Mr. Ahmed Ahmed is telling us who can have access to glp1 agonists.
Transcript (auto-generated)
This transcript was generated automatically and may contain errors.
Who can get access to these weight loss drugs? Everyone can get access to these weight loss drugs if they meet the criteria for weight management. These drugs are available at the moment for diabetics in the National Health the National Health Service. For non-diabetics, at the moment, they would need to seek out a private doctor to prescribe these. However, we are told that at the end of 2022, these drugs should also be available for non-diabetic obese patients in the NHS.
Health Shared
Comments